Primary effusion lymphoma (PEL) is an uncommon subtype of B‐cell lymphoma that presents primarily as lymphomatous effusions in body cavities, rather than as solid masses. Traditionally ...

Primary effusion lymphoma (PEL) is a rare, aggressive B‐cell neoplasm most commonly associated with infection by human herpesvirus 8 (HHV8) and, in many instances, co‐infection with Epstein ...

A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and facial droop on the left side. Computed tomography showed a nasopharyngeal mass. A diagnosis was made.

Citius Oncology has completed commercial-scale manufacturing of LYMPHIR, with packaged and labeled inventory now held at a leading global Contract Development and Manufacturing Organization (CDMO).

The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with ...

Roche has demonstrated the power of combining two of oncology's hottest modalities—bispecifics and antibody-drug conjugates ...

The Food and Drug Administration (FDA) has approved Monjuvi ® (tafasitamab-cxix), in combination with lenalidomide and rituximab, for the treatment of adult patients with relapsed or refractory (R/R) ...

Adding tafasitamab to treatment with lenalidomide and rituximab improved outcomes in patients with relapsed or refractory follicular lymphoma.

Further testing with mammography, colonoscopy, and upper endoscopy failed to identify any primary site. Molecular profiling to find the tissue of origin and identify targetable genomic alterations ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma. In a post on social media ...